FBT vs XLV: holdings overlap, shared companies and scores
As of October 28, 2026, FBT and XLV overlap 11.5% by weight. First Trust NYSE Arca Biotechnology Index Fund (FBT): U.S. biotech stocks. State Street Health Care Select Sector SPDR ETF (XLV): U.S. healthcare sector.
Updated October 28, 2026
Where FBT and XLV trade against their own history
FBT trades at 31.9 times earnings, against its own median of 21.1, and is more expensive than 94% of its own last 6 years.
XLV trades at 33.4 times earnings, against its own median of 25.1, and is more expensive than 98% of its own last 9 years.
What moved FBT this week
FBT rose 2.6% in the week to October 28, 2026. The holdings that moved it most were Genmab A/S (+44.8%), Veracyte (+8.8%) and TG Therapeutics (+7.9%); Corcept Therapeutics (−25.8%) pushed the other way.
What do FBT and XLV each hold?
36% of FBT is its ten largest holdings.
What's inside XLV: AI 0%.
61% of XLV is its ten largest holdings.
How much do FBT and XLV overlap? 11.5% by weight
As of October 28, 2026, FBT and XLV overlap 11.5% by weight.
27% of FBT is already inside XLV.
12% of XLV is already inside FBT.
FBT holds 30 companies and XLV holds 61; 8 are in both.
Computed by ETF Copilot from both funds' holdings rather than quoted from a data provider, and rebuilt nightly.
How does ETF Copilot score FBT and XLV? 5.4 and 5.4 out of 10
As of October 28, 2026, ETF Copilot scores FBT 5.4 out of 10 and XLV 5.4 out of 10.
They differ most on Quality: FBT 2.0 and XLV 6.9.
The five factor scores behind them are set out below, 0–10 and higher is better, ranked against every US equity ETF we track.
| Factor | FBT | XLV |
|---|---|---|
| Growth | 9.8 | 5.8 |
| Value | 0.2 | 0.7 |
| Risk | 4.1 | 8.3 |
| Quality | 2.0 | 6.9 |
| Return | 7.6 | 5.3 |
XLV is the cheaper of the two at 0.08% a year
As of October 28, 2026, FBT charges 0.55% a year and holds $3.0B in assets across 30 positions.
As of October 28, 2026, XLV charges 0.08% a year, yields 1.42% and holds $47.0B in assets across 61 positions.
| Measure | FBT | XLV |
|---|---|---|
| Expense ratio | 0.55% | 0.08% |
| Dividend yield | — | 1.42% |
| Assets under management | $3.0B | $47.0B |
| Holdings | 30 | 61 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Compare with similar funds
Cite this
ETF Copilot, “FBT vs XLV holdings overlap and scores”, as of October 28, 2026.
https://etf-copilot.com/compare/fbt-vs-xlv
- First Trust NYSE Arca Biotechnology Index Fund (FBT)
- State Street Health Care Select Sector SPDR ETF (XLV)
ETF Copilot Pro unlocks FBT vs XLV prices and holdings.
Try Pro free →